Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abigail Allen-Gondringer

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Cytoskeleton (Hoboken, N.J.)|December 28, 2024
Author Profile: Abigail Allen-GondringerAbigail Allen-Gondringer
Cytoskeleton (Hoboken, N.J.)|April 16, 2024
Haplo-insufficiency of Profilin1 in vascular endothelial cells is beneficial but not sufficient to confer protection against experimentally induced atherosclerosisAbigail Allen-Gondringer, David Gau, Partha Dutta, et al.
Biorxiv : the Preprint Server for Biology|December 18, 2023
Haplo-insufficiency of Profilin1 in vascular endothelial cells is beneficial but not sufficient to confer protection against experimentally induced atherosclerosisAbigail Allen-Gondringer, David Gau, Partha Dutta, et al.
PNAS Nexus|October 2, 2023
Vascular endothelial cell-specific disruption of the <i>profilin1</i> gene leads to severe multiorgan pathology and inflammation causing mortalityAbigail Allen-Gondringer, David Gau, Christopher Varghese, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Cytoskeleton (Hoboken, N.J.)|December 28, 2024
Author Profile: Abigail Allen-GondringerAbigail Allen-Gondringer
Cytoskeleton (Hoboken, N.J.)|April 16, 2024
Haplo-insufficiency of Profilin1 in vascular endothelial cells is beneficial but not sufficient to confer protection against experimentally induced atherosclerosisAbigail Allen-Gondringer, David Gau, Partha Dutta, et al.
Biorxiv : the Preprint Server for Biology|December 18, 2023
Haplo-insufficiency of Profilin1 in vascular endothelial cells is beneficial but not sufficient to confer protection against experimentally induced atherosclerosisAbigail Allen-Gondringer, David Gau, Partha Dutta, et al.
PNAS Nexus|October 2, 2023
Vascular endothelial cell-specific disruption of the <i>profilin1</i> gene leads to severe multiorgan pathology and inflammation causing mortalityAbigail Allen-Gondringer, David Gau, Christopher Varghese, et al.
Pageof 1